IL-28A Is a Key Regulator of T-Cell-Mediated Liver Injury via the T-Box Transcription Factor T-Bet

Gastroenterology

Volumn 132, Issue 1, 2007, Pages 358-371

  Siebler, Juergen ^a   Wirtz, Stefan ^a   Weigmann, Benno ^a   Atreya, Imke ^a   Schmitt, Edgar ^a   Kreft, Andreas ^a   Galle, Peter R ^a   Neurath, Markus F ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; CONCANAVALIN A; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 28A; INTERLEUKIN 4; OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATE; RECOMBINANT INTERCELLULAR ADHESION MOLECULE 1; TRANSCRIPTION FACTOR T BET; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; COMPARATIVE STUDY; CONTROLLED STUDY; CROSS REACTION; CYTOKINE PRODUCTION; DISEASE MODEL; DRUG TARGETING; HEPATITIS; IN VIVO STUDY; LIVER INJURY; MEDIATOR; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE; TH1 CELL; TRANSGENIC MOUSE; UPREGULATION; WILD TYPE;

EID: 33846197963     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2006.10.028     Document Type: Article

References (51)

1. Pestka S., Krause C.D., and Walter M.R. Interferons, interferon-like cytokines, and their receptors. Immunol Rev 202 (2004) 8-32
2. Kotenko S.V., Gallagher G., Baurin V.V., Lewis-Antes A., Shen M., Shah N.K., Langer J.A., Sheikh F., Dickensheets H., and Donnelly R.P. IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex. Nat Immunol 4 (2003) 69-77
3. Sheppard P., Kindsvogel W., Xu W., Henderson K., Schlutsmeyer S., Whitmore T.E., Kuestner R., Garrigues U., Birks C., Roraback J., Ostrander C., Dong D., Shin J., Presnell S., Fox B., Haldeman B., Cooper E., Taft D., Gilbert T., Grant F.J., Tackett M., Krivan W., McKnight G., Clegg C., Foster D., and Klucher K.M. IL-28, IL-29 and their class II cytokine receptor IL-28R. Nat Immunol 4 (2003) 63-68
4. Siren J., Pirhonen J., Julkunen I., and Matikainen S. IFN-alpha regulates TLR-dependent gene expression of IFN-alpha, IFN-beta, IL-28, and IL-29. J Immunol 174 (2005) 1932-1937
5. Pellegrini S., and Schindler C. Early events in signalling by interferons. Trends Biochem Sci 18 (1993) 338-342
6. Donnelly R.P., Dickensheets H., and Finbloom D.S. The interleukin-10 signal transduction pathway and regulation of gene expression in mononuclear phagocytes. J Interferon Cytokine Res 19 (1999) 563-573
7. Dumoutier L., Tounsi A., Michiels T., Sommereyns C., Kotenko S.V., and Renauld J.C. Role of the interleukin (IL)-28 receptor tyrosine residues for antiviral and antiproliferative activity of IL-29/interferon-lambda 1: similarities with type I interferon signaling. J Biol Chem 279 (2004) 32269-32274
8. Robek M.D., Boyd B.S., and Chisari F.V. Lambda interferon inhibits hepatitis B and C virus replication. J Virol 79 (2005) 3851-3854
9. Kempuraj D., Donelan J., Frydas S., Iezzi T., Conti F., Boucher W., Papadopoulou N.G., Madhappan B., Letourneau L., Cao J., Sabatino G., Meneghini F., Stellin L., Verna N., Riccioni G., and Theoharides T.C. Interleukin-28 and 29 (IL-28 and IL-29): new cytokines with anti-viral activities. Int J Immunopathol Pharmacol 17 (2004) 103-106
10. Lohoff M., Schmitt E., Reske-Kunz A.B., and Rollinghoff M. Different response of TH1 cells for stimulation with anti-CD3 antibodies. Eur J Immunol 20 (1990) 653-658
11. Ohara J., and Paul W.E. Production of a monoclonal antibody to and molecular characterization of B-cell stimulatory factor-1. Nature 315 (1985) 333-336
12. Karasuyama H., and Melchers F. Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4 or 5, using modified cDNA expression vectors. Eur J Immunol 18 (1988) 97-104
13. Zhumabekov T., Corbella P., Tolaini M., and Kioussis D. Improved version of a human CD2 minigene based vector for T cell-specific expression in transgenic mice. J Immunol Methods 185 (1995) 133-140
14. Becker C., Wirtz S., Blessing M., Pirhonen J., Strand D., Bechthold O., Frick J., Galle P.R., Autenrieth I., and Neurath M.F. Constitutive p40 promoter activation and IL-23 production in the terminal ileum mediated by dendritic cells. J Clin Invest 112 (2003) 693-706
15. Neurath M.F., Weigmann B., Finotto S., Glickman J., Nieuwenhuis E., Iijima H., Mizoguchi A., Mizoguchi E., Mudter J., Galle P.R., Bhan A., Autschbach F., Sullivan B.M., Szabo S.J., Glimcher L.H., and Blumberg R.S. The transcription factor T-bet regulates mucosal T cell activation in experimental colitis and Crohn's disease. J Exp Med 195 (2002) 1129-1143
16. Seki S., Habu Y., Kawamura T., Takeda K., Dobashi H., Ohkawa T., and Hiraide H. The liver as a crucial organ in the first line of host defense: the roles of Kupffer cells, natural killer (NK) cells and NK1.1 Ag+ T cells in T helper 1 immune responses. Immunol Rev 174 (2000) 35-46
17. Biburger M., and Tiegs G. Alpha-galactosylceramide-induced liver injury in mice is mediated by TNF-alpha but independent of Kupffer cells. J Immunol 175 (2005) 1540-1550
18. Kusters S., Gantner F., Kunstle G., and Tiegs G. Interferon gamma plays a critical role in T cell-dependent liver injury in mice initiated by concanavalin A. Gastroenterology 111 (1996) 462-471
19. Tagawa Y., Sekikawa K., and Iwakura Y. Suppression of concanavalin A-induced hepatitis in IFN-gamma(-/-) mice, but not in TNF-alpha(-/-) mice: role for IFN-gamma in activating apoptosis of hepatocytes. J Immunol 159 (1997) 1418-1428
20. Tiegs G., Hentschel J., and Wendel A. A T cell-dependent experimental liver injury in mice inducible by concanavalin A. J Clin Invest 90 (1992) 196-203
21. Takeda K., Hayakawa Y., Van Kaer L., Matsuda H., Yagita H., and Okumura K. Critical contribution of liver natural killer T cells to a murine model of hepatitis. Proc Natl Acad Sci U S A 97 (2000) 5498-5503
22. Siebler J., Wirtz S., Klein S., Protschka M., Blessing M., Galle P.R., and Neurath M.F. A key pathogenic role for the STAT1/T-bet signaling pathway in T-cell-mediated liver inflammation. Hepatology 38 (2003) 1573-1580
23. Klein C., Wustefeld T., Assmus U., Roskams T., Rose-John S., Muller M., Manns M.P., Ernst M., and Trautwein C. The IL-6-gp130-STAT3 pathway in hepatocytes triggers liver protection in T cell-mediated liver injury. J Clin Invest 115 (2005) 860-869
24. Di Marco R., Xiang M., Zaccone P., Leonardi C., Franco S., Meroni P., and Nicoletti F. Concanavalin A-induced hepatitis in mice is prevented by interleukin (IL)-10 and exacerbated by endogenous IL-10 deficiency. Autoimmunity 31 (1999) 75-83
25. Radaeva S., Sun R., Pan H.N., Hong F., and Gao B. Interleukin 22 (IL-22) plays a protective role in T cell-mediated murine hepatitis: IL-22 is a survival factor for hepatocytes via STAT3 activation. Hepatology 39 (2004) 1332-1342
26. Donnelly R.P., Sheikh F., Kotenko S.V., and Dickensheets H. The expanded family of class II cytokines that share the IL-10 receptor-2 (IL-10R2) chain. J Leukoc Biol 76 (2004) 314-321
27. Rogge L., D'Ambrosio D., Biffi M., Penna G., Minetti L.J., Presky D.H., Adorini L., and Sinigaglia F. The role of Stat4 in species-specific regulation of Th cell development by type I IFNs. J Immunol 161 (1998) 6567-6574
28. Gimeno R., Lee C.K., Schindler C., and Levy D.E. Stat1 and Stat2 but not Stat3 arbitrate contradictory growth signals elicited by alpha/beta interferon in T lymphocytes. Mol Cell Biol 25 (2005) 5456-5465
29. Schindler C.W. JAK-STAT signaling in human disease. J Clin Invest 109 (2002) 1133-1137
30. Neurath M.F., Finotto S., and Glimcher L.H. The role of Th1/Th2 polarization in mucosal immunity. Nat Med 8 (2002) 567-573
31. Bouma G., and Strober W. The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol 3 (2003) 521-533
32. MacDonald T.T., and Monteleone G. Immunity, inflammation, and allergy in the gut. Science 307 (2005) 1920-1925
33. MacDonald T.T. The mucosal immune system. Parasite Immunol 25 (2003) 235-246
34. Singh K., Zonin F., Vaisberg E., Churakova T., Liu M., Gorman D., Wagner J., Zurawski S., Liu Y., Abrams J.S., Moore K.W., Rennick D., de Waal-Malefyt R., Hannum C., Bazan J.F., and Kastelein R.A. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 13 (2000) 715-725
35. Hunter C.A. New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions. Nat Rev Immunol 5 (2003) 521-531
36. Pflanz S., Timans J.C., Cheung J., Rosales R., Kanzler H., Gilbert J., Hibbert L., Churakova T., Travis M., Vaisberg E., Blumenschein W.M., Mattson J.D., Wagner J.L., To W., Zurawski S., McClanahan T.K., Gorman D.M., Bazan J.F., de Waal Malefyt R., Rennick D., and Kastelein R.A. IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4(+) T cells. Immunity 16 (2002) 779-790
37. Harrington L.E., Hatton R.D., Mangan P.R., Turner H., Murphy T.L., Murphy K.M., and Weaver C.T. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 6 (2005) 1123-1132
38. Park H., Li Z., Yang X.O., Chang S.H., Nurieva R., Wang Y.H., Wang Y., Hood L., Zhu Z., Tian Q., and Dong C. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 6 (2005) 1133-1141
39. Trinchieri G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol 3 (2003) 133-146
40. Villarino A., Hibbert L., Lieberman L., Wilson E., Mak T., Yoshida H., Kastelein R.A., Saris C., and Hunter C.A. The IL-27R (WSX-1) is required to suppress T cell hyperactivity during infection. Immunity 19 (2003) 645-655
41. Owaki T., Asakawa M., Morishima N., Hata K., Fukai F., Matsui M., Mizuguchi J., and Yoshimoto T. A role for IL-27 in early regulation of Th1 differentiation. J Immunol 175 (2005) 2191-2200
42. Kamiya S., Owaki T., Morishima N., Fukai F., Mizuguchi J., and Yoshimoto T. An indispensable role for STAT1 in IL-27-induced T-bet expression but not proliferation of naive CD4+ T cells. J. Immunol 173 (2004) 3871-3877
43. Lucas S., Ghilardi N., Li J., and de Sauvage F.J. IL-27 regulates IL-12 responsiveness of naive CD4+ T cells through Stat1-dependent and -independent mechanisms. Proc Natl Acad Sci U S A 100 (2003) 15047-15052
44. Hwang E.S., Szabo S.J., Schwartzberg P.L., and Glimcher L.H. T helper cell fate specified by kinase-mediated interaction of T-bet with GATA-3. Science 307 (2005) 430-433
45. Szabo S.J., Sullivan B.M., Stemmann C., Satoskar A.R., Sleckman B.P., and Glimcher L.H. Distinct effects of T-bet in TH1 lineage commitment and IFN-gamma production in CD4 and CD8 T cells. Science 295 (2002) 338-342
46. Finotto S., Neurath M.F., Glickman J.N., Qin S., Lehr H.A., Green F.H., Ackerman K., Haley K., Galle P.R., Szabo S.J., Drazen J.M., De Sanctis G.T., and Glimcher L.H. Development of spontaneous airway changes consistent with human asthma in mice lacking T-bet. Science 295 (2002) 336-338
47. Afkarian M., Sedy J.R., Yang J., Jacobson N.G., Cereb N., Yang S.Y., Murphy T.L., and Murphy K.M. T-bet is a STAT1-induced regulator of IL-12R expression in naive CD4+ T cells. Nat Immunol 3 (2002) 549-557
48. Schindler C., and Strehlow I. Cytokines and STAT signaling. Adv Pharmacol 47 (2000) 113-174
49. Hong F., Jaruga B., Kim W.H., Radaeva S., El-Assal O.N., Tian Z., Nguyen V.A., and Gao B. Opposing roles of STAT1 and STAT3 in T cell-mediated hepatitis: regulation by SOCS. J Clin Invest 110 (2002) 1503-1513
50. Weigmann B., and Neurath M.F. T-bet as a possible therapeutic target in autoimmune disease. Expert Opin Ther Targets 6 (2002) 619-622
51. Finotto S., and Glimcher L. T cell directives for transcriptional regulation in asthma. Springer Semin Immunopathol 25 (2004) 281-294